3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Neonatal Abstinence Syndrome: new trials by email Literature Review of Neonatal Abstinence Syndrome trials Research Report on Neonatal Abstinence Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure Buprenorphine - Neonatal Abstinence Syndrome, Neonatal Opiate Withdrawal Syndrome | Phase 1 / Phase 2 | Completed | Thomas Jefferson University | 10 | 2018-08-29 | 2022-02-11 |
| Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines oral morphine, sublingual buprenorphine - Neonatal Abstinence Syndrome | Phase 1 | Completed | Thomas Jefferson University | 11 | 2012-08-01 | 2016-10-14 |
| Buprenorphine for the Treatment of Neonatal Abstinence Syndrome buprenorphine, Oral morphine solution - Neonatal Abstinence Syndrome | Phase 1 | Completed | Thomas Jefferson University | 60 | 2004-04-01 | 2017-01-12 |
Chemically-Induced Disorders (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Infant, Newborn, Diseases (3) · Mental Disorders (3) · Substance-Related Disorders (3)
Buprenorphine (3) · Morphine (2)
Thomas Jefferson University (3)
United States (3)
Walter K Kraft, MD (2) · Walter K Kraft, MD, MS (1)
PMID 18694901, PMID 20925688, PMID 34080312
R21DA018207 (1)